The importance of understanding cost burden in CF

The recently published scoping review on the economic burden of cystic fibrosis (CF) summarizes much of the research on this important topic [1]. Economic burden can be reported from three different views: cost to a person, cost to the healthcare system, and societal cost. This review correctly points out that much of the current literature focuses on costs to the health care system and not the totality of financial burden experienced by people living with CF. Perhaps more importantly, there is even less published evidence available on the impacts associated with these costs on the individual level.
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: Source Type: research